Shaanxi Meibang Pharmaceutical Group Co., Ltd.
SSE:605033.SS
16.97 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 885.528 | 699.027 | 906.046 | 842.49 | 568.518 | 515.708 | 438.56 | 421.959 |
| Cost of Revenue
| 632.741 | 478.04 | 518.855 | 520.062 | 361.863 | 314.166 | 274.345 | 267.486 |
| Gross Profit
| 252.787 | 220.987 | 387.19 | 322.428 | 206.655 | 201.542 | 164.215 | 154.473 |
| Gross Profit Ratio
| 0.285 | 0.316 | 0.427 | 0.383 | 0.363 | 0.391 | 0.374 | 0.366 |
| Reseach & Development Expenses
| 74.327 | 58.53 | 80.043 | 63.807 | 51.365 | 39.517 | 26.932 | 26.353 |
| General & Administrative Expenses
| 11.98 | 9.286 | 7.925 | 11.589 | 4.82 | 5.165 | 9.458 | 11.962 |
| Selling & Marketing Expenses
| 49.239 | 85.423 | 122.647 | 88.266 | 45.888 | 45.747 | 35.84 | 35.242 |
| SG&A
| 61.219 | 94.709 | 130.572 | 99.855 | 50.708 | 50.913 | 45.298 | 47.204 |
| Other Expenses
| 86.599 | 12.042 | 26.054 | 19.744 | 13.032 | 12.075 | 0.554 | 0.058 |
| Operating Expenses
| 222.145 | 188.732 | 236.669 | 183.406 | 115.104 | 102.505 | 83.233 | 75.704 |
| Operating Income
| 30.642 | 50.368 | 140.273 | 122.504 | 87.594 | 86.049 | 66.861 | 69.878 |
| Operating Income Ratio
| 0.035 | 0.072 | 0.155 | 0.145 | 0.154 | 0.167 | 0.152 | 0.166 |
| Total Other Income Expenses Net
| 7.216 | 12.042 | 12.094 | 16.327 | 1.792 | -0.545 | -4.19 | 0.058 |
| Income Before Tax
| 37.858 | 62.41 | 152.368 | 138.831 | 89.386 | 85.504 | 67.415 | 69.936 |
| Income Before Tax Ratio
| 0.043 | 0.089 | 0.168 | 0.165 | 0.157 | 0.166 | 0.154 | 0.166 |
| Income Tax Expense
| 0.999 | 4.853 | 7.279 | 13.088 | 10.652 | 9.247 | 8.085 | 8.711 |
| Net Income
| 36.859 | 57.557 | 145.088 | 125.743 | 78.734 | 76.257 | 59.33 | 61.225 |
| Net Income Ratio
| 0.042 | 0.082 | 0.16 | 0.149 | 0.138 | 0.148 | 0.135 | 0.145 |
| EPS
| 0.27 | 0.43 | 1.07 | 0.93 | 0.58 | 0.56 | 0.63 | 0.68 |
| EPS Diluted
| 0.27 | 0.43 | 1.07 | 0.93 | 0.58 | 0.56 | 0.63 | 0.68 |
| EBITDA
| 59.615 | 84.134 | 150.045 | 154.616 | 100.897 | 97.794 | 79.922 | 79.119 |
| EBITDA Ratio
| 0.067 | 0.12 | 0.166 | 0.184 | 0.177 | 0.19 | 0.182 | 0.188 |